FAMDF Projected Dividend Yield

Ord/Futura Medical Plc ( OTCBB : FAMDF )

Futura Medical is engaged in the research and development of pharmaceutical drugs and medical devices and the commercial exploitation for the prescription and consumer healthcare in sexual health and pain relief. Co. is engaged in the development of transdermal technology platform, DermaSys® for the absorption of active molecules through the skin. Through its DermaSys® technology, Co is in the progress of the development and regulatory approval for MED3000, a treatment for erectile dysfunction; and TPR100, a topical non-steroidal anti-inflammatory diclofenac pain relief gel for the pain and inflammation associated with sprains, strains, bruises and soft tissue rheumatism.

20 YEAR PERFORMANCE RESULTS